WO2003055528A2 - Composes amphiphiles a usage pharmaceutique ou cosmetique - Google Patents
Composes amphiphiles a usage pharmaceutique ou cosmetique Download PDFInfo
- Publication number
- WO2003055528A2 WO2003055528A2 PCT/FR2002/004561 FR0204561W WO03055528A2 WO 2003055528 A2 WO2003055528 A2 WO 2003055528A2 FR 0204561 W FR0204561 W FR 0204561W WO 03055528 A2 WO03055528 A2 WO 03055528A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phase
- amino acid
- biologically active
- active molecule
- compound according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002472124A CA2472124A1 (fr) | 2001-12-27 | 2002-12-24 | Composes amphiphiles a usage pharmaceutique ou cosmetique |
US10/499,542 US20050069513A1 (en) | 2001-12-27 | 2002-12-24 | Amphiphilic compounds for pharmaceutical or cosmetic use |
AU2002364684A AU2002364684A1 (en) | 2001-12-27 | 2002-12-24 | Amphiphilic compounds for pharmaceutical or cosmetic use |
EP02805808A EP1458415A2 (fr) | 2001-12-27 | 2002-12-24 | Composes amphiphiles a usage pharmaceutique ou cosmetique |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0116936A FR2834215B1 (fr) | 2001-12-27 | 2001-12-27 | Composes amphiphiles a usage pharmaceutique ou cosmetique |
FR01/16936 | 2001-12-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003055528A2 true WO2003055528A2 (fr) | 2003-07-10 |
WO2003055528A3 WO2003055528A3 (fr) | 2004-02-26 |
Family
ID=8871028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2002/004561 WO2003055528A2 (fr) | 2001-12-27 | 2002-12-24 | Composes amphiphiles a usage pharmaceutique ou cosmetique |
Country Status (6)
Country | Link |
---|---|
US (1) | US20050069513A1 (fr) |
EP (1) | EP1458415A2 (fr) |
AU (1) | AU2002364684A1 (fr) |
CA (1) | CA2472124A1 (fr) |
FR (1) | FR2834215B1 (fr) |
WO (1) | WO2003055528A2 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011141685A2 (fr) | 2010-05-14 | 2011-11-17 | Physica Pharma Sas | Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants |
WO2012114054A1 (fr) | 2011-02-24 | 2012-08-30 | Physica Pharma Sas | Compositions pharmaceutiques à action locale administrables par application cutanée |
WO2012114051A1 (fr) | 2011-02-24 | 2012-08-30 | Physica Pharma Sas | Compositions pharmaceutiques administrables par voie cutanée et destinées au traitement local de la dermatite atopique canine |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5853755A (en) * | 1993-07-28 | 1998-12-29 | Pharmaderm Laboratories Ltd. | Biphasic multilamellar lipid vesicles |
WO2001035998A1 (fr) * | 1999-11-12 | 2001-05-25 | Pharmaderm Laboratories, Ltd. | Compositions pour administration transdermique et transmuqueuse d'agents therapeutiques |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US442090A (en) * | 1890-12-02 | Edwin t | ||
DE2111361B2 (de) * | 1971-03-10 | 1973-02-15 | Verwendung von n-acylaminosaeuren, deren salzen und/oder estern als emulgatoren | |
FR2289179A1 (fr) * | 1974-10-28 | 1976-05-28 | Morelle Jean | Sels metalliques de lipoaminoacides |
US4837026A (en) * | 1985-10-03 | 1989-06-06 | Rajakhyaksha Vithal J | Transdermal and systemic preparation and method |
JP3202777B2 (ja) * | 1992-01-24 | 2001-08-27 | リンテック株式会社 | 経皮吸収促進剤及びテープ製剤 |
EP0788346B9 (fr) * | 1994-03-18 | 2007-02-14 | Supernus Pharmaceuticals, Inc. | Systemes d'administration de medicaments emulsionnes |
FR2828102B1 (fr) * | 2001-03-28 | 2004-07-09 | Ifc Sa | Utilisation des lipoaminoacides dans une composition pharmaceutique comme promoteur et systeme disperse a usage pharmaceutique contenant de tels composes |
-
2001
- 2001-12-27 FR FR0116936A patent/FR2834215B1/fr not_active Expired - Fee Related
-
2002
- 2002-12-24 AU AU2002364684A patent/AU2002364684A1/en not_active Abandoned
- 2002-12-24 CA CA002472124A patent/CA2472124A1/fr not_active Abandoned
- 2002-12-24 EP EP02805808A patent/EP1458415A2/fr not_active Withdrawn
- 2002-12-24 WO PCT/FR2002/004561 patent/WO2003055528A2/fr not_active Application Discontinuation
- 2002-12-24 US US10/499,542 patent/US20050069513A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5853755A (en) * | 1993-07-28 | 1998-12-29 | Pharmaderm Laboratories Ltd. | Biphasic multilamellar lipid vesicles |
WO2001035998A1 (fr) * | 1999-11-12 | 2001-05-25 | Pharmaderm Laboratories, Ltd. | Compositions pour administration transdermique et transmuqueuse d'agents therapeutiques |
Non-Patent Citations (6)
Title |
---|
GULATI MONICA ET AL: "Lipophilic drug derivatives in liposomes." INTERNATIONAL JOURNAL OF PHARMACEUTICS (AMSTERDAM), vol. 165, no. 2, 14 mai 1998 (1998-05-14), pages 129-168, XP002214801 ISSN: 0378-5173 * |
NASH R A ET AL: "The possibility of lidocaine ion pair absorption through excised hairless mouse skin." SKIN PHARMACOLOGY: THE OFFICIAL JOURNAL OF THE SKIN PHARMACOLOGY SOCIETY. SWITZERLAND 1992, vol. 5, no. 3, 1992, pages 160-170, XP002044700 ISSN: 1011-0283 * |
See also references of EP1458415A2 * |
TONDRE C ET AL: "Properties of the amphiphilic films in mixed cationic/anionic vesicles: a comprehensive view from a literature analysis." ADVANCES IN COLLOID AND INTERFACE SCIENCE. NETHERLANDS 8 OCT 2001, vol. 93, no. 1-3, 8 octobre 2001 (2001-10-08), pages 115-134, XP002214799 ISSN: 0001-8686 * |
VALENTA C ET AL: "The dermal delivery of lignocaine: Influence of ion pairing." INTERNATIONAL JOURNAL OF PHARMACEUTICS (KIDLINGTON)., vol. 197, no. 1-2, 20 mars 2000 (2000-03-20), pages 77-85, XP002214800 ISSN: 0378-5173 * |
WOO G T ET AL: "EMULSIONS PREPARED BY INTERFACIAL ION PAIR FORMATIONS BETWEEN AMINO ACIDS AND FATTY ACIDS" JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 76, no. 11, 1987, page S306, XP002214798 ISSN: 0022-3549 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011141685A2 (fr) | 2010-05-14 | 2011-11-17 | Physica Pharma Sas | Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants |
WO2012114054A1 (fr) | 2011-02-24 | 2012-08-30 | Physica Pharma Sas | Compositions pharmaceutiques à action locale administrables par application cutanée |
WO2012114051A1 (fr) | 2011-02-24 | 2012-08-30 | Physica Pharma Sas | Compositions pharmaceutiques administrables par voie cutanée et destinées au traitement local de la dermatite atopique canine |
Also Published As
Publication number | Publication date |
---|---|
US20050069513A1 (en) | 2005-03-31 |
CA2472124A1 (fr) | 2003-07-10 |
FR2834215A1 (fr) | 2003-07-04 |
WO2003055528A3 (fr) | 2004-02-26 |
AU2002364684A1 (en) | 2003-07-15 |
FR2834215B1 (fr) | 2004-07-16 |
EP1458415A2 (fr) | 2004-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sarciaux et al. | Using microemulsion formulations for oral drug delivery of therapeutic peptides | |
Sintov et al. | Systemic delivery of insulin via the nasal route using a new microemulsion system: in vitro and in vivo studies | |
WO1996033697A1 (fr) | Formulation auto-emulsionnable formant une emulsion huile dans l'eau | |
WO2002076506A1 (fr) | Utilisation de lipoaminoacides comme promoteurs d'absorption dans une composition pharmaceutique | |
EP0004223A1 (fr) | Procédé de fabrication de capsules lipidiques renfermant un matériau biologiquement actif, produits obtenus par ce procédé ainsi que leur utilisation | |
CA2748713C (fr) | Composition comprenant un actif de faible solubilite aqueuse | |
Wei et al. | Hollow quaternized chitosan microspheres increase the therapeutic effect of orally administered insulin | |
WO2000044348A2 (fr) | Materiels et procedes de production de compositions micellaires ameliorees | |
WO2011141685A2 (fr) | Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants | |
CA2682250A1 (fr) | Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique | |
EP0491921B1 (fr) | Procede de preparation d'une lipoproteine modifiee par incorporation d'une substance active lipophile | |
FR2954163A1 (fr) | Utilisation d'un tensioactif cationique, avantageu-sement amphotere, pour la preparation d'une composition antifongique applicable sur l'ongle | |
WO2003055528A2 (fr) | Composes amphiphiles a usage pharmaceutique ou cosmetique | |
WO2001049264A2 (fr) | Compositions pharmaceutiques destinees a une administration par voie orale | |
EP0726760B1 (fr) | Formulation auto-emulsionnable formant une huile dans eau | |
EP2482853B1 (fr) | Transport cooperatif de principes actifs basiques par des molecules amphiphiles acides | |
FR2787029A1 (fr) | Utilisation dans une composition pharmaceutique pour l'administration par voie nasale de vitamine b12 pour la delivrance d'agents actifs au systeme nerveux central | |
Nieto-Suárez et al. | Behavior of insulin–sphingomyelin mixed Langmuir monolayers spread at the air–water interface | |
EP4316466A1 (fr) | Chitosomes ou liposomes recouverts de chitosane, leur utilisation dans l'obtention de compositions cosmétiques ou pharmaceutiques et leur procédé de préparation | |
Vauthier et al. | Contribution to the development of oral dosage forms for insulin delivery | |
OA10033A (en) | Solution hypertonique de cisplatine | |
FR2771929A1 (fr) | Utilisation dans une composition pharmaceutique pour l'administration par voie nasale de particules hydrophiles pour la delivrance d'agents actifs au systeme nerveux central | |
FR3124953A1 (fr) | Forme galénique à base de pulpe de baobab, procédés de préparation et utilisations | |
FR2828101A1 (fr) | Utilisation des lipoaminoacides dans une composition pharmaceutique comme promoteurs d'absorption et systeme disperse a usage pharmaceutique contenant de tels composes | |
Bykov et al. | Influence of Various Pharmaceutical Factors on Drug Release from Matrix Tablets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002805808 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2472124 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 2002805808 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10499542 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |